Gene Query: UQCRC2

Dataset Description Geneva Score
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 31.87
RNAseq of HEK293 cells after Chtop knockdown 24.92
Co-transcriptional loading of RNA export factors shapes the human transcriptome 24.92
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 21.89
Mitochondrial dsRNA triggers antiviral signalling in humans 20.42
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 19.58
Sensing self and nonself circular RNAs 18.66
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 18.6
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 18.3
3’ Uridylation Expands miRNA Target Repertoire 18.04
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 17.62
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 17.62
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 17.38
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 17.19
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 15.81
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 15.39
KLF6-dependent transcription in renal cancer cells 15.06
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 15.04
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 14.78
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 14.65
H1609088 Human RNA-Sequencing 14.48
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 14.42
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 14.39
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 14.21
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 14.16
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 14.13
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 14.02
Role of XRN2 ribonucleolytic activity in RNA metabolism 13.86
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 13.73
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 13.53
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 13.35
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 13.21
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 13.21
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 13.21
RNA sequencing of primary human platelets and in vitro cell lines 13.19
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 13.12
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 13.09
Effect of Influenza virus infection on lncRNA expression in A549 cells 13.05
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 12.44
Crizotinib v. DMSO in SW480 cells 12.4
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 12.25
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 12.15
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 12.03
The pioneer factor CEBPA modulates vitamin D signaling 11.98
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 11.98
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 11.95
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 11.86
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 11.86
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 11.38
RNA seq comparison between scrambled and shGRP78 cells 11.34
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 11.26
hnRNP C is a key regulator of protein synthesis in mitosis 11.23
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 10.99
ZIKV infection of monocytes activates inflammasome pathways 10.99
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 10.86
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 10.86
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 10.76
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 10.74
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 10.7
RNA m5C Methylation in breast cancer using MeRIP-Seq 10.69
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 10.65
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 10.64
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 10.63
RIG-I and MDA5 fRIP during KSHV lytic reactivation 10.58
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 10.57
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 10.33
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 10.2
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 10.19
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 10.16
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 10.15
CROP-Seq in Primary Human T Cells 10.08
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 10.04
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 9.94
Global analysis of enhancer targets: Mosaic-seq 9.81
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 9.76
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 9.74
Splicing and epigenetic factors jointly regulate epidermal differentiation 9.73
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 9.73
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 9.71
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 9.7
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 9.6
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.51
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 9.5
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 9.5
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 9.49
Transcriptomic analysis of human tonsillar TFH subsets 9.49
NRDE2 negatively regulates nuclear exosome functions 9.46
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.44
Human cells contain natural double-stranded RNAs with potential regulatory capacity 9.41
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 9.3
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 9.2
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 9.19
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 9.18
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 9.16
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 9.02
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.02
An RNA-centric dissection of host complexes controlling flavivirus infection 8.98
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 8.98
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 8.96
RNA-seq analysis of BAP1-depleted uveal melanoma cells 8.93
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 8.81
METTL3 and WTAP 8.78
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 8.74
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 8.7
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 8.7
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.69
Gene expression analysis of immortalized human liver progenitor-like cells in culture 8.67
The human blood-nerve barrier transcriptome 8.55
Control of prostate tumour growth by the long non-coding RNA GHSROS 8.42
TOP2B disturbed the quality of human oocytes with advanced maternal age 8.41
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 8.41
Human cell line and subcutaneous tumor 8.36
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 8.35
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.27
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 8.22
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 8.21
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 8.21
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 8.19
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 8.17
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 8.15
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 8.15
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 8.15
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 8.13
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 8.12
Reassessment of Exosome Composition 7.89
Short and Long RNA sequencing of human mature erythrocytes 7.83
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 7.83
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 7.82
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 7.82
The transcriptome and chromatin accessbility landscape of mammalian germline 7.77
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 7.68
Patient-derived luminal breast cancer xenografts with progestins 7.68
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 7.68
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 7.66
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 7.65
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 7.65
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.63
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.63
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 7.61
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 7.51
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 7.5
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 7.48
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 7.48
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 7.48
Regulation of highly expressed hCINAP on translatome 7.38
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 7.37
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 7.37
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 7.34
Transcriptomic and gene ontology profiling of the human corneal cell types 7.3
Transcriptomic analysis of the HOTAIR-regulated genes 7.27
RNAseq Study in CC-671 Treated Cal-51 Cells 7.26
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 7.21
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.16
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 7.14
Exploring the RNA landscape of endothelial exosomes 7.1
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 7.09
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 7.08
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 7.07
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.06
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 7.01
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.98
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.98
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 6.98
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 6.97
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 6.89
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 6.81
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 6.81
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 6.79
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 6.79
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 6.77
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 6.72
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 6.72
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 6.7
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.68
Transcriptomic analyssis following EHMT1/2 inhibition 6.68
SF3B1 Degron knockdown RNA-seq 6.64
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 6.59
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.57
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 6.53
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 6.53
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.5
Identifying the molecular mode of action of itraconazole in colorectal cancer 6.47
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 6.45
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 6.42
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 6.42
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 6.4
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 6.4
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 6.4
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 6.34
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 6.33
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 6.33
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 6.33
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 6.33
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 6.33
RNA Sequencing of three pairs of gastric cancer 6.29
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.25
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 6.25
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 6.24
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.23
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 6.22
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.2
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.2
Identification of renal resident macrophages across species 6.2
RNA-Seq with and without RNase treatment in PCa cell lines 6.19
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 6.17
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 6.17
miR941 overexpression experiment 6.1
Determination of tRNA aminoacylation levels by high throughput sequencing 6.09
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 6.08
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 6.07
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 6.05
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 6.04
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.03
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 6.03
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 5.96
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 5.95
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 5.95
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 5.83
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 5.81
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 5.79
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 5.72
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 5.72
Unique features and clinical importance of acute alloreactive immune responses 5.65
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 5.64
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 5.63
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.63
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.63
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 5.55
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 5.41
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 5.41
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 5.36
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 5.3
Regulation of protein translation during mitosis 5.24
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 5.23
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.22
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 5.18
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.18
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.15
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 5.15
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 5.1
Gene expression changes upon drug withdrawal (Mel888 cell line) 5.08
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.08
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.06
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.02
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.02
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.99
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.99
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 4.97
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 4.97
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 4.88
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 4.87
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.86
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.86
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 4.85
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 4.84
Ribosome profiling upon inhibition of eIF4A 4.83
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 4.83
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 4.83
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 4.81
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 4.79
Regulatory network controlling tumor-promoting inflammation in human cancers 4.77
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 4.77
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 4.75
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.64
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 4.61
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 4.56
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 4.55
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 4.5
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 4.5
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.48
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.48
miR-93 Targets in Human Endothelial Cells 4.41
scRNASeq analysis of cycling cardiomyocytes 4.4
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.39
RNA-seq of RKO cells with cTAZ KO or putback 4.38
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 4.37
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 4.36
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 4.36
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 4.36
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.29
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.28
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.28
RNAseq in Alzheimer's Disease patients 4.27
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 4.26
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 4.25
Gene expression profile in breast cancer cells 4.25
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.2
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 4.14
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 4.13
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 4.13
X-Ray induced DNA-Hydroxymethylation changes 4.12
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 4.12
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 4.07
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 4.07
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 4.05
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 4.03
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 3.99
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 3.94
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 3.92
IMP3 regulated gene expression in breast cancer cells 3.92
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.9
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 3.9
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.89
RNA-seq of cancer cell lines treated with T-025 3.86
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.86
Molecular Criteria for Defining the Naive Human Pluripotent State 3.84
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 3.84
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.82
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.79
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 3.78
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 3.78
N6-methyladenine DNA Modification in Glioblastoma 3.76
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.76
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 3.75
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 3.66
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 3.66
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 3.66
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.66
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.66
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 3.64
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 3.64
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.64
Identification of renal resident macrophages across species [C1] 3.63
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 3.6
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 3.46
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 3.45
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 3.41
Single-cell analysis of human kidney organoids 3.35
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 3.34
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.34
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.34
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 3.28
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 3.28
Positively selected enhancer elements endow tumor cells with metastatic competence 3.25
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 3.23
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 3.2
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.18
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.18
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.14
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.14
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.11
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.05
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.05
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.03
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 3.02
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 2.99
Peptidomimetic blockade of MYB in acute myeloid leukemia 2.99
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.98
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.98
The transcriptome of Kawasaki Disease arteritis 2.98
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.96
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.94
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 2.92
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.91
Transcriptome analysis of peripheral blood monocytes 2.88
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.83
Transcriptome of diurnal human blood neutrophils 2.79
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.78
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.78
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.75
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 2.74
Transcriptome analysis of CNS leukemia 2.73
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.73
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.7
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.64
Activity-dependent transcriptional changes in human neurons 2.64
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 2.64
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 2.64
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.62
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 2.61
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.49
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.44
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.41
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.31
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.31
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 2.28
p63 controls the enhancer landscape during keratinocyte differentiation 2.16
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.15
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 2.12
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 2.12
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 2.1
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 2.1
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.08
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.06
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 2.06
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 2.06
Differential gene expression profiles in imatinib-resistant cell lines 2.05
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.05
Determining mRNA half-lives on a transcriptome-wide scale 2.05
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.04
Induced DNA demethylation, genome instability and transcription 2.04
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 2.04
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.97
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.84
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.83
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 1.82
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.78
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.77
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.77
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.76
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.75
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.75
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.74
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.68
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.66
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.66
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.65
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.64
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.64
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.61
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.59
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.57
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.55
Dilated cardiomyopathy vs Myocarditis 1.49
Differential Protein Occupancy Profiling of the mRNA Transcriptome 1.49
mRNA expression in human DAOY cells 1.48
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.46
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.45
SLAM-seq for K562 endogenous mRNA decay 1.42
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.41
RNA seq_PDX2_SHP099 1.38
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.37
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.36
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.34
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.32
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.32
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.32
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.31
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.25
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.25
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.23
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.23
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.21
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.21
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.21
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.15
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.14
An optimization system for isolating and sequencing of single human colon cancer cells 1.09
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.06
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.05
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.04
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 1.02
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.0
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.95
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.88
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.87
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.87
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.87
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 0.84
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.83
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.82
RNA-seq of primary patient AML samples 0.8
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.79
Metabolism as an early predictor of DPSCs aging 0.78
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.75
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.75
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.72
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.72
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.71
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 0.7
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.69
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.69
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 0.68
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.67
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.61
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.59
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.59
p53 activity results in DNA replication fork processivity 0.56
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.56
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.54
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.54
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.53
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.5
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.46
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.45
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.43
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.42
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.4
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.36
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.33
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.33
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.32
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.29
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.29
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.25
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.24
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.22
Transcriptional landscape changes during human embryonic stem cell derivation 0.22
Comparative Analysis of Cas9 Activators Across Multiple Species 0.21
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.21
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.2
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.2
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.19
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.08
Interphase condensins regulate ligand-depedent enhancer activation 0.06
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.06
Transcriptomic analysis of human macrophages in 3D 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation